BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25402252)

  • 1. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
    Novaes HM; Elias FT
    Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
    Caetano R; Hauegen RC; Osorio-de-Castro CGS
    Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances and challenges to the Brazilian policy of health technology management].
    Silva HP; Petramale CA; Elias FT
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():83-90. PubMed ID: 23223789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.
    Elias FT; Araújo DV
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):405-12. PubMed ID: 25444299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment in Brazil - an international perspective.
    Lima SGG; Brito C; Andrade CJC
    Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health technology assessment: experience in the Ministry of Health of Brazil].
    Silva MT
    Rev Peru Med Exp Salud Publica; 2011; 28(3):548-51. PubMed ID: 22086639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incorporation of technologies by the Canadian and Brazilian health systems: prospects for progress in assessment processes].
    Silva HPD; Elias FTS
    Cad Saude Publica; 2019 Aug; 35(suppl 2):e00071518. PubMed ID: 31432894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
    Yazdani S; Jadidfard MP
    Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of health technology assessment in Brazil.
    Banta D; Almeida RT
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():255-9. PubMed ID: 19538816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
    Yuba TY; Novaes HMD; de Soárez PC
    Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
    Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
    Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment in Saudi Arabia.
    Al-Aqeel S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):393-402. PubMed ID: 29733227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?].
    Campolina AG; Soárez PC; Amaral FVD; Abe JM
    Cad Saude Publica; 2017 Oct; 33(10):e00045517. PubMed ID: 29091169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Technology Assessment and Its Use in Drug Policies in China.
    Zhen X; Sun X; Dong H
    Value Health Reg Issues; 2018 May; 15():138-148. PubMed ID: 29729645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment development in China.
    Chen Y; Banta D; Tang Z
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():202-9. PubMed ID: 19575825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
    Kahveci R; Koç EM; Küçük EÖ
    Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of health technology assessment in China: New challenges.
    Chen Y; He Y; Chi X; Wei Y; Shi L
    Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.